Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PREP | P48147 | 3/20 | 0.55 |
| ▸ | ACE2 | Q9BYF1 | 3/20 | 0.54 |
| ▸ | TSHR | P16473 | 1/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | PRCP | P42785 | 1/20 | 0.53 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.52 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.52 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.52 |
| ▸ | GFER | P55789 | 1/20 | 0.50 |
| ▸ | NPC1 | O15118 | 1/20 | 0.50 |
| ▸ | RAB9A | P51151 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | CTRB1 | P17538 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14646665 | 0.96 | TMEM97 (0.56) | PREPACE2TSHRL3MBTL1KDM4E | |
| SCHEMBL19621551 | 0.96 | TMEM97 (0.56) | PREPACE2TSHRL3MBTL1KDM4E | |
| SCHEMBL809534 | 0.90 | PREP (0.57) | PREPACE2TSHRL3MBTL1KDM4E | |
| SCHEMBL16414618 | 0.88 | PREP (0.54) | PREPACE2TSHRL3MBTL1KDM4E | |
| SCHEMBL9092052 | 0.87 | PREP (0.53) | PREPACE2TSHRL3MBTL1KDM4E | |
| SCHEMBL29599061 | 0.87 | PREP (0.53) | PREPACE2TSHRL3MBTL1KDM4E | |
| SCHEMBL18506025 | 0.87 | PREP (0.50) | PREPACE2TSHRL3MBTL1KDM4E | |
| SCHEMBL3354292 | 0.86 | PREP (0.54) | PREPACE2NPSR1TMEM97SIGMAR1 | |
| SCHEMBL22158059 | 0.86 | PREP (0.54) | PREPACE2TSHRL3MBTL1KDM4E | |
| SCHEMBL13060873 | 0.86 | PREP (0.54) | PREPACE2TSHRL3MBTL1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150218192-A1 | Polysilylated Organosilane Compounds | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S.) (FR) | 2015-08-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150218192-A1 | Polysilylated Organosilane Compounds | ALG8, UGT1A9, SI | PREP 2037/4885ACE2 2760/4885TSHR 4451/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.